AU684087B2 - Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin - Google Patents

Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin Download PDF

Info

Publication number
AU684087B2
AU684087B2 AU70760/94A AU7076094A AU684087B2 AU 684087 B2 AU684087 B2 AU 684087B2 AU 70760/94 A AU70760/94 A AU 70760/94A AU 7076094 A AU7076094 A AU 7076094A AU 684087 B2 AU684087 B2 AU 684087B2
Authority
AU
Australia
Prior art keywords
document
date
modafinil
cited
documents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU70760/94A
Other languages
English (en)
Other versions
AU7076094A (en
Inventor
Philippe Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Sante SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU684087(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of AU7076094A publication Critical patent/AU7076094A/en
Application granted granted Critical
Publication of AU684087B2 publication Critical patent/AU684087B2/en
Assigned to TEVA SANTE reassignment TEVA SANTE Request to Amend Deed and Register Assignors: LABORATOIRE L. LAFON
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AU70760/94A 1993-06-22 1994-06-14 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin Expired AU684087B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (Direct) 1993-06-22 1993-06-22
FR9307555 1993-06-22
PCT/FR1994/000711 WO1995000132A1 (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale

Publications (2)

Publication Number Publication Date
AU7076094A AU7076094A (en) 1995-01-17
AU684087B2 true AU684087B2 (en) 1997-12-04

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70760/94A Expired AU684087B2 (en) 1993-06-22 1994-06-14 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin

Country Status (14)

Country Link
US (1) US5612379A (Direct)
EP (1) EP0705099B1 (Direct)
JP (1) JP3703831B2 (Direct)
KR (1) KR100315389B1 (Direct)
AT (1) ATE207351T1 (Direct)
AU (1) AU684087B2 (Direct)
CA (1) CA2165824C (Direct)
DE (1) DE69428791T2 (Direct)
DK (1) DK0705099T3 (Direct)
ES (1) ES2165878T3 (Direct)
FR (1) FR2706767B1 (Direct)
HU (1) HU216731B (Direct)
PT (1) PT705099E (Direct)
WO (1) WO1995000132A1 (Direct)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
PT1066036E (pt) 1998-02-27 2006-09-29 Univ Illinois Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
PT1330244E (pt) * 2000-10-11 2009-01-27 Cephalon Inc Composições compreendendo compostos de modafinil
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
ES2281527T3 (es) * 2001-05-25 2007-10-01 Cephalon, Inc. Formulaciones farmaceuticas solidas que comprenden modafinilo.
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
ES2487415T3 (es) * 2003-03-17 2014-08-20 Neurohealing Pharmaceuticals, Inc. Tratamiento dopaminérgico de alta potencia de deficiencias neurológicas asociadas con lesiones cerebrales
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
AU2005319367B2 (en) * 2004-12-20 2012-05-24 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP1909573A4 (en) * 2005-07-21 2010-09-22 Neurohealing Pharmaceuticals I SHORT-TERM EFFECTIVE MODAFINIL COMPOSITIONS WITH A RAPID INITIAL EFFECT, AND METHOD FOR THEIR USE
KR20090031618A (ko) * 2006-07-12 2009-03-26 엘란 코포레이션, 피엘씨 나노입자형 모다피닐 제제
US7884135B2 (en) * 2006-08-14 2011-02-08 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
AU2011203970A1 (en) * 2010-01-07 2012-07-12 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
CN105658227B (zh) 2013-08-30 2020-04-03 绿十字生命健康有限公司 含有人参皂苷成分得到增加的加工人参粉末或加工人参提取物的用于预防及治疗癌因性疲乏的组合物
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
ES2165878T3 (es) 2002-04-01
FR2706767A1 (Direct) 1994-12-30
CA2165824C (fr) 2005-08-02
WO1995000132A1 (fr) 1995-01-05
HUT74674A (en) 1997-01-28
ATE207351T1 (de) 2001-11-15
FR2706767B1 (Direct) 1995-09-08
KR960703009A (ko) 1996-06-19
HU9503702D0 (en) 1996-02-28
JP3703831B2 (ja) 2005-10-05
US5612379A (en) 1997-03-18
JPH09500374A (ja) 1997-01-14
KR100315389B1 (ko) 2002-02-19
DK0705099T3 (da) 2002-02-11
DE69428791T2 (de) 2002-07-04
EP0705099A1 (fr) 1996-04-10
AU7076094A (en) 1995-01-17
DE69428791D1 (de) 2001-11-29
EP0705099B1 (fr) 2001-10-24
PT705099E (pt) 2002-03-28
HU216731B (hu) 1999-08-30
CA2165824A1 (fr) 1995-01-05

Similar Documents

Publication Publication Date Title
AU684087B2 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
Taranto-Montemurro et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial
Becker et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure.
Pagel et al. Medications for the treatment of sleep disorders: an overview
Mamelak et al. Treatment of narcolepsy and sleep apnea with gammahydroxybutyrate: a clinical and polysomnographic case study
Berry et al. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea
JPS62111924A (ja) 恐慌障害の軽減剤
Walton et al. Ketorolac and diclofenac for postoperative pain relief following oral surgery
DE60111025T2 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
Zhu et al. Dental management of children with asthma
Baghani et al. The dental management of the asthmatic patients
Buckle et al. Nocturnal cluster headache associated with sleep apnea. A case report
JP2501033B2 (ja) Ｄ―フェンフルラミン含有うつ病用医薬組成物
Goold Postoperative spasticity and shivering: a review with personal observations of 500 patients
Oham et al. Subcutaneous ketamine prolongs the analgesic effect of local infiltration of plain Bupivacaine in children undergoing inguinal herniotomy
DE60100660T2 (de) Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien
JPH08512311A (ja) 慢性疲労症候群治療用ヒ素医薬
Kim et al. Transdermal scopolamine alters phasic REM activity in normal young adults
Castillo et al. Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS)
CN101229170A (zh) 米氮平用于治疗睡眠障碍的用途
Rhodes et al. A comparison of the effects of zolpidem and placebo on respiration and oxygen saturation during sleep in the healthy elderly.
Weksler et al. Lidocaine pretreatment effectively decreases the incidence of hiccups during methohexitone administration for dilatation and curettage
Owens et al. Nebulized atropine sulfate in the treatment of acute asthma
Adrian et al. Profiles of patients with maxillofacial fractures in emergency department of head and neck surgery division of Dr. Soetomo General Hospital Surabaya in 2021 during COVID-19 pandemic
Bachrach et al. Clinical observations on the use of alphaprodine (nisentil) for postoperative analgesia